vs
Side-by-side financial comparison of Five9, Inc. (FIVN) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $300.3M, roughly 1.6× Five9, Inc.). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs -1.7%). Over the past eight quarters, Five9, Inc.'s revenue compounded faster (10.3% CAGR vs -0.1%).
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FIVN vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.3M | $493.8M |
| Net Profit | — | $33.7M |
| Gross Margin | 55.4% | — |
| Operating Margin | 6.6% | 9.9% |
| Net Margin | — | 6.8% |
| Revenue YoY | 7.8% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $0.22 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $300.3M | $493.8M | ||
| Q3 25 | $285.8M | $492.9M | ||
| Q2 25 | $283.3M | $468.8M | ||
| Q1 25 | $279.7M | $458.4M | ||
| Q4 24 | $278.7M | $502.4M | ||
| Q3 24 | $264.2M | $511.2M | ||
| Q2 24 | $252.1M | $504.3M | ||
| Q1 24 | $247.0M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $18.0M | $71.7M | ||
| Q2 25 | $1.2M | $39.3M | ||
| Q1 25 | $576.0K | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-4.5M | $19.4M | ||
| Q2 24 | $-12.8M | $-153.0M | ||
| Q1 24 | $-7.1M | $4.0M |
| Q4 25 | 55.4% | — | ||
| Q3 25 | 55.0% | — | ||
| Q2 25 | 54.9% | — | ||
| Q1 25 | 55.0% | — | ||
| Q4 24 | 56.0% | — | ||
| Q3 24 | 53.8% | — | ||
| Q2 24 | 53.0% | — | ||
| Q1 24 | 53.6% | — |
| Q4 25 | 6.6% | 9.9% | ||
| Q3 25 | 5.6% | 13.8% | ||
| Q2 25 | -0.6% | 12.8% | ||
| Q1 25 | -1.9% | 7.0% | ||
| Q4 24 | 1.5% | 7.8% | ||
| Q3 24 | -5.8% | 6.6% | ||
| Q2 24 | -7.7% | -31.3% | ||
| Q1 24 | -8.4% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 6.3% | 14.5% | ||
| Q2 25 | 0.4% | 8.4% | ||
| Q1 25 | 0.2% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -1.7% | 3.8% | ||
| Q2 24 | -5.1% | -30.3% | ||
| Q1 24 | -2.9% | 0.8% |
| Q4 25 | $0.22 | $0.40 | ||
| Q3 25 | $0.21 | $0.84 | ||
| Q2 25 | $0.01 | $0.46 | ||
| Q1 25 | $0.01 | $0.24 | ||
| Q4 24 | $0.16 | $0.37 | ||
| Q3 24 | $-0.06 | $0.23 | ||
| Q2 24 | $-0.17 | $-1.84 | ||
| Q1 24 | $-0.10 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.1M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $785.8M | $865.9M |
| Total Assets | $1.8B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.1M | $375.2M | ||
| Q3 25 | $193.4M | $340.1M | ||
| Q2 25 | $205.5M | $224.7M | ||
| Q1 25 | $370.3M | $99.0M | ||
| Q4 24 | $362.5M | $229.9M | ||
| Q3 24 | $291.0M | $103.8M | ||
| Q2 24 | $175.7M | $19.4M | ||
| Q1 24 | $240.2M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $785.8M | $865.9M | ||
| Q3 25 | $775.3M | $890.7M | ||
| Q2 25 | $717.4M | $833.8M | ||
| Q1 25 | $664.3M | $789.2M | ||
| Q4 24 | $622.2M | $764.9M | ||
| Q3 24 | $565.6M | $732.5M | ||
| Q2 24 | $525.9M | $706.5M | ||
| Q1 24 | $483.6M | $856.2M |
| Q4 25 | $1.8B | $2.2B | ||
| Q3 25 | $1.8B | $2.2B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $2.1B | $2.0B | ||
| Q4 24 | $2.1B | $2.2B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.0B | ||
| Q1 24 | $1.9B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $114.1M |
| Free Cash FlowOCF − Capex | $77.3M | — |
| FCF MarginFCF / Revenue | 25.8% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $201.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.6M | $114.1M | ||
| Q3 25 | $59.2M | $137.3M | ||
| Q2 25 | $35.1M | $137.2M | ||
| Q1 25 | $48.4M | $-117.5M | ||
| Q4 24 | $49.8M | $133.0M | ||
| Q3 24 | $41.1M | $91.8M | ||
| Q2 24 | $19.9M | $107.0M | ||
| Q1 24 | $32.4M | $-125.2M |
| Q4 25 | $77.3M | — | ||
| Q3 25 | $48.7M | — | ||
| Q2 25 | $31.6M | — | ||
| Q1 25 | $43.7M | — | ||
| Q4 24 | $40.5M | — | ||
| Q3 24 | $26.7M | — | ||
| Q2 24 | $13.1M | — | ||
| Q1 24 | $20.4M | — |
| Q4 25 | 25.8% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 4.8% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 3.29× | 1.91× | ||
| Q2 25 | 30.38× | 3.49× | ||
| Q1 25 | 84.00× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIVN
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
